Nabriva Therapeutics plc

Nabriva Therapeutics plc

NBRVF
Nabriva Therapeutics plcUS flagOther OTC
0.00
USD
- -
- -
323.00Market Cap

Nabriva Therapeutics plc (NBRVF) Stock Split History

Learn about Nabriva Therapeutics plc's most recent 1-for-25 basis stock split on September 16, 2022. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Nabriva Therapeutics plc's most recent stock split

Split Date: 2022-09-16
Split Ratio: 1:25
Price Before Split: N/A
Price After Split: N/A

Developer API

Get NBRVF split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/NBRVF

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 25.00 times fewer shares (a 1:25 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Nabriva Therapeutics plc's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2022-09-161:25YesN/AN/A
2020-12-031:10YesN/AN/A
2017-06-2610:1NoN/AN/A

About Nabriva Therapeutics plc

Company overview and industry information

Nabriva Therapeutics plc (NBRVF) operates in the Biotechnology industry. The recent 1-for-25 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Nabriva Therapeutics plc Summary

Last updated: 7/12/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.